ZYXP1

Across TCGA pan-cancer cohorts, ZYXP1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated ZYXP1 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher ZYXP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZYXP1 expression acts as an unfavorable survival marker.

ESCA, HNSC, and SKCM are the cancer types where ZYXP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
HNSC	OS	Tertile	IV	0.187	0.649	.005	18	view →
SKCM	DFS	Tertile	III,IV	0.195	0.599	.034	9	view →
BRCA	OS	Tertile	All	0.780	0.963	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ZYXP1–ESCA (OS)

Open the ESCA breakdown →